High Forest Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
3
- Portfolio
-
3
High Forest General Information
Company Description
High Forest is a venture capital firm based in London, United Kingdom. The firm focuses on early-stage companies in the biopharmaceutical industry.
Business Details
Website
www.highforest.ukInvestor Status
Primary Investor Type
Corporate Office
- 2 Merrivale Terrace
- Distillery Road
- London W6 9HD
- England, United Kingdom
High Forest Investments (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| RNAimmune | 21-Apr-2021 | Seed Round | Drug Discovery | Clinical Trials - Phase 1 | ||
| Genor BioPharma | 07-Oct-2020 | Biotechnology | Generating Revenue | |||
| Flowerstreet54 | Hotels and Resorts | Generating Revenue |
High Forest Investments by Industry, Year, and Region
High Forest FAQs
-
What is High Forest?
High Forest is a venture capital firm based in London, United Kingdom.
-
Where is High Forest headquartered?
High Forest is headquartered in London, United Kingdom.
-
How many investments has High Forest made?
High Forest has made 3 investments.
-
What has High Forest invested in?
High Forest has made numerous investments in companies like RNAimmune, Genor BioPharma, and Flowerstreet54 within the Drug Discovery, Biotechnology, and Hotels and Resorts industries.
-
What has High Forest invested in recently?
High Forest's latest investment was on 21-Apr-2021 in RNAimmune, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process